Table 2.
Rate of disease progression in patients with all LRRK2 mutations and LRRK2 Gly2019Ser
|
Time of progression to H and Y stage |
Proportion of patients at each H and Y stage with PD for 10 years or longer |
|||
|---|---|---|---|---|
| All mutations (n=321) | Gly2019Ser (n=291) | All mutations (n= 257) | Gly2019Ser (n=226) | |
| H and Y stage 1 | 4·0 years | 4·1 years | 6% | 6% |
| H and Y stage 2 | 7·2 years | 7·4 years | 27% | 31% |
| H and Y stage 3 | 9·4 years | 9·1 years | 45% | 44% |
| H and Y stage 4 | 12·6 years | 12·9 years | 57% | 61% |
| H and Y stage 5 | 15·6 years | 16·2 years | 79% | 82% |
Average number of years it took each patient to reach each stage of the H and Y scale and the percentage of patients at each stage who had symptoms for 10 years or longer. H and Y=Hoehn and Yahr scale